ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FEMY Femasys Inc

0.8701
-0.0119 (-1.35%)
Dec 08 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 257,884
Bid Price 0.8707
Ask Price 0.89
News (1)
Day High 0.89

Low
0.2479

52 Week Range

High
4.75

Day Low 0.86
Share Name Share Symbol Market Stock Type
Femasys Inc FEMY NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0119 -1.35% 0.8701 18:58:31
Open Price Low Price High Price Close Price Previous Close
0.88 0.86 0.89 0.889 0.882
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
645 257,884 US$ 0.8776941 US$ 226,343 - 0.2479 - 4.75
Last Trade Type Quantity Price Currency
18:31:01 formt 500 US$ 0.8701 USD

Femasys Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
19.05M 21.65M - 1.21M -11.39M -0.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Femasys News

Date Time Source News Article
12/08/202308:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
11/30/202316:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
11/29/202315:05Edgar (US Regulatory)Form 8-K - Current report
11/22/202315:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/22/202315:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
11/22/202315:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of Securities
11/21/202316:30Edgar (US Regulatory)Form 8-K - Current report
11/15/202316:19Edgar (US Regulatory)Form 8-K - Current report
11/15/202307:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging..
11/01/202320:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/11/202307:01Edgar (US Regulatory)Form 8-K - Current report
10/03/202308:28Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FEMY Message Board. Create One! See More Posts on FEMY Message Board See More Message Board Posts

Historical FEMY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.900.9501610.860.9083605378,499-0.0299-3.32%
1 Month1.251.250.84010.98128511,289,424-0.3799-30.39%
3 Months0.35754.750.24792.2111,102,9160.5126143.38%
6 Months0.81264.750.24791.837,059,8330.05757.08%
1 Year1.104.750.24791.833,572,916-0.2299-20.9%
3 Years13.0813.750.24791.961,530,154-12.21-93.35%
5 Years13.0813.750.24791.961,530,154-12.21-93.35%

Femasys Description

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com